WHAT IS THE IMPACT OF ADDING EXTRA HEALTH DIMENSIONS TO THE EQ-5D?

Published Apr 15, 2015
Oxford, UK  -  Generic preference-based measures of health are commonly used to evaluate the impact of diseases and their treatments on overall health related quality of life by weighting their dimensions using people’s value judgements. However, these measures, including the EQ-5D, may miss key dimensions of health for some conditions. A team of researchers from Oxford University, Brunel University, and Sheffield University explored the potential solution of adding extra dimensions to the EQ-5D, a practice known as a ‘bolt-on’ approach. They developed three dimensions describing hearing impairment, vision impairment, and tiredness to add separately to the five core dimensions of the EQ-5D. Interviews were undertaken among 300 members of the UK general public to elicit people’s preferences for the health states with and without the extra dimensions, and data were analysed to examine the magnitude and direction of impact on health state values of the extra dimensions. Study co-author, Dr. Yaling Yang, PhD, from the University of Oxford concluded, “Each of the bolt-on dimensions had a significant impact on values for EQ-5D health states. The extent and direction of the impact of the bolt-on varied according to the level of severity of the bolt-on dimension and the severity of the state to which it was added. The results of this research suggest that simple valuation of these bolt-on items may not be possible; however, further research is required to confirm this exploratory finding.” The full study, “An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5D,” is available Open Access in Value in Health.

Related Stories

Promoting Fairness in Funding Decisions

Jun 24, 2026

Value in Health announced the publication of a special themed section of research papers that offer new tools to help health policy makers weigh fairness alongside cost-effectiveness when deciding which treatments and programs to fund.

Listening to Patients in the Real World

Jun 23, 2026

Value in Health, the official journal of ISPOR announced today the publication of an ISPOR Good Practices Report outlining 9 areas to strengthen the robustness, transparency, and feasibility of real-world patient-reported outcomes studies.

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×